MX2009004802A - Incremento de las defensas pulmonares del hospedero mediante la administracion del factor estimulador de colonias de granulositos-macrofagos. - Google Patents
Incremento de las defensas pulmonares del hospedero mediante la administracion del factor estimulador de colonias de granulositos-macrofagos.Info
- Publication number
- MX2009004802A MX2009004802A MX2009004802A MX2009004802A MX2009004802A MX 2009004802 A MX2009004802 A MX 2009004802A MX 2009004802 A MX2009004802 A MX 2009004802A MX 2009004802 A MX2009004802 A MX 2009004802A MX 2009004802 A MX2009004802 A MX 2009004802A
- Authority
- MX
- Mexico
- Prior art keywords
- pneumonia
- granulocyte
- fungal
- bacterial
- stimulating factor
- Prior art date
Links
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 title abstract 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 title abstract 2
- 230000007123 defense Effects 0.000 title abstract 2
- 230000002708 enhancing effect Effects 0.000 title abstract 2
- 230000002685 pulmonary effect Effects 0.000 title abstract 2
- 206010035664 Pneumonia Diseases 0.000 abstract 4
- 230000001580 bacterial effect Effects 0.000 abstract 3
- 230000002538 fungal effect Effects 0.000 abstract 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 2
- 208000031888 Mycoses Diseases 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 2
- 201000009805 cryptogenic organizing pneumonia Diseases 0.000 abstract 2
- 230000009385 viral infection Effects 0.000 abstract 2
- 206010006448 Bronchiolitis Diseases 0.000 abstract 1
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 1
- 208000008745 Healthcare-Associated Pneumonia Diseases 0.000 abstract 1
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 206010029888 Obliterative bronchiolitis Diseases 0.000 abstract 1
- 241000233872 Pneumocystis carinii Species 0.000 abstract 1
- 208000009470 Ventilator-Associated Pneumonia Diseases 0.000 abstract 1
- 201000009267 bronchiectasis Diseases 0.000 abstract 1
- 201000003848 bronchiolitis obliterans Diseases 0.000 abstract 1
- 208000023367 bronchiolitis obliterans with obstructive pulmonary disease Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 206010062952 diffuse panbronchiolitis Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86419006P | 2006-11-03 | 2006-11-03 | |
| US94751107P | 2007-07-02 | 2007-07-02 | |
| PCT/DK2007/050161 WO2008052567A2 (en) | 2006-11-03 | 2007-11-02 | Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009004802A true MX2009004802A (es) | 2009-08-12 |
Family
ID=39344625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009004802A MX2009004802A (es) | 2006-11-03 | 2007-11-02 | Incremento de las defensas pulmonares del hospedero mediante la administracion del factor estimulador de colonias de granulositos-macrofagos. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100015217A1 (enExample) |
| EP (1) | EP2094290B1 (enExample) |
| JP (3) | JP2010508365A (enExample) |
| AU (1) | AU2007315402B2 (enExample) |
| BR (1) | BRPI0717958B8 (enExample) |
| CA (1) | CA2668292C (enExample) |
| MX (1) | MX2009004802A (enExample) |
| WO (1) | WO2008052567A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008116470A1 (en) * | 2007-03-26 | 2008-10-02 | Drugrecure Aps | Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor |
| EP2688583A4 (en) | 2011-03-22 | 2014-10-29 | Univ Texas | PROTECTION AGAINST INFLUENZA INFECTIONS BY THE GRANULOCYTE MACROPHAGENCOLONIA STIMULATING FACTOR |
| WO2012136224A2 (en) * | 2011-04-07 | 2012-10-11 | Trifoilium Aps | Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy |
| JP2014529614A (ja) * | 2011-08-29 | 2014-11-13 | トリフォイリウム・エピエス | 放射線により誘発されるまたは化学療法により誘発される肺機能不全の治療または予防のための組成物および方法 |
| EP2850176B1 (en) * | 2012-05-18 | 2019-01-16 | Syracuse University | Controlling pseudomonas aeruginosa persister cells with gm-csf |
| WO2014012559A1 (en) * | 2012-07-20 | 2014-01-23 | Trifoilium Aps | Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma |
| WO2014096032A1 (en) * | 2012-12-18 | 2014-06-26 | Trifoilium Aps | Gm-csf for treatment of chronic sinusitis |
| WO2014128173A1 (en) | 2013-02-20 | 2014-08-28 | Trifoilium Aps | Gm-csf for treatment of chronic oral mucositis |
| WO2015110536A1 (en) * | 2014-01-22 | 2015-07-30 | Reponex Pharmaceuticals Aps | Granulocyte-macrophage colony-stimulating factor for the treatment and prevention of severe forms of bronchial asthma |
| WO2015132392A1 (en) * | 2014-03-07 | 2015-09-11 | Reponex Pharmaceuticals Aps | Compositions for treating lung infections by airway administration |
| JP2017524655A (ja) * | 2014-05-23 | 2017-08-31 | レポネックス・ファーマシューティカルズ・エーピーエス | 創傷の治癒を促進するための組成物 |
| US10105415B2 (en) | 2014-07-24 | 2018-10-23 | Reponex Pharmaceuticals A/S | Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease |
| CA3079117A1 (en) * | 2017-10-16 | 2019-04-25 | Drugrecure Aps | Gm-csf for treating refractory non-tuberculous mycobacteria infections |
| WO2021188883A1 (en) * | 2020-03-20 | 2021-09-23 | The Regents Of The University Of Colorado, A Body Corporate | Methods and compositions for the treatment of viral disease using granulocyte-macrophage colony-stimulating factor (gm-csf) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) * | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5391485A (en) * | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| US5162111A (en) * | 1986-07-30 | 1992-11-10 | Grabstein Kenneth H | Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor |
| US4837028A (en) * | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US9269067B2 (en) * | 2002-04-04 | 2016-02-23 | Altisource Solutions S.À.R.L. | Method and apparatus for providing selective access to information |
| US7512585B2 (en) | 2002-07-11 | 2009-03-31 | Oracle International Corporation | Support for multiple mechanisms for accessing data stores |
-
2007
- 2007-11-02 BR BRPI0717958A patent/BRPI0717958B8/pt active IP Right Grant
- 2007-11-02 MX MX2009004802A patent/MX2009004802A/es active IP Right Grant
- 2007-11-02 CA CA2668292A patent/CA2668292C/en active Active
- 2007-11-02 WO PCT/DK2007/050161 patent/WO2008052567A2/en not_active Ceased
- 2007-11-02 EP EP07817959.5A patent/EP2094290B1/en active Active
- 2007-11-02 AU AU2007315402A patent/AU2007315402B2/en active Active
- 2007-11-02 JP JP2009535569A patent/JP2010508365A/ja active Pending
- 2007-11-02 US US12/513,215 patent/US20100015217A1/en not_active Abandoned
-
2013
- 2013-09-25 JP JP2013198117A patent/JP2014028839A/ja active Pending
-
2015
- 2015-10-16 JP JP2015204558A patent/JP6001151B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2094290B1 (en) | 2017-07-19 |
| CA2668292A1 (en) | 2008-05-08 |
| JP2016040300A (ja) | 2016-03-24 |
| BRPI0717958A2 (pt) | 2013-11-05 |
| WO2008052567A3 (en) | 2009-01-22 |
| BRPI0717958B8 (pt) | 2021-05-25 |
| AU2007315402A1 (en) | 2008-05-08 |
| AU2007315402B2 (en) | 2013-05-16 |
| BRPI0717958B1 (pt) | 2019-12-10 |
| CA2668292C (en) | 2018-04-03 |
| JP2010508365A (ja) | 2010-03-18 |
| JP6001151B2 (ja) | 2016-10-05 |
| JP2014028839A (ja) | 2014-02-13 |
| US20100015217A1 (en) | 2010-01-21 |
| EP2094290A2 (en) | 2009-09-02 |
| WO2008052567A2 (en) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009004802A (es) | Incremento de las defensas pulmonares del hospedero mediante la administracion del factor estimulador de colonias de granulositos-macrofagos. | |
| JP2010508365A5 (enExample) | ||
| MX346244B (es) | Composiciones de vancomicina en polvo seco y metodos asociados. | |
| WO2012047674A3 (en) | Methods and compositions for disease treatment using inhalation | |
| JP2014028839A5 (enExample) | ||
| EP4620525A3 (en) | Methods and compositions for treatment of pulmonary hypertension and other lung disorders | |
| WO2008147482A3 (en) | Methods and compositions for improving immune responses | |
| JP2016513688A5 (enExample) | ||
| WO2009099998A3 (en) | Therapeutic treatment for lung conditions | |
| HRP20200661T1 (hr) | Razine ceramida u liječenju i prevenciji infekcija | |
| Dinc et al. | Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis | |
| NZ715882A (en) | Tissue targeted antigenic activation of the immune response to treat cancers | |
| MX2020010977A (es) | Procedimientos de tratamiento de infecciones fúngicas. | |
| CN102228309B (zh) | 小茴香吸品及其制法 | |
| JP2014529614A5 (enExample) | ||
| RU2014111818A (ru) | Композиции и способы для лечения или предупреждения легочной дисфункции, вызываемой лучевой терапией или химиотерапией | |
| WO2010025577A3 (de) | Zubereitung zur prävention und/oder behandlung und/oder verhinderung der weiterverbreitung von atemwegserkrankungen | |
| AR064883A1 (es) | Aumento de las defensas pulmonares del huesped mediante la administracion de factor estimulador de colonias de granulocitos-macrofagos | |
| CN103690914B (zh) | 一种治疗风寒犯肺证型肺病的中药 | |
| Kobayashi et al. | Hydrogen Gas Inhalation Ameliorates Lung And Distal Organ Injury In A Murine Aspiration Pneumonia Model | |
| Okamoto et al. | Muc5b expression is increased in a murine model of hypersensitivity pneumonitis | |
| RU2533284C1 (ru) | Способ лечения среднетяжелой атопической бронхиальной астмы бытовой этиологии у пациентов с иммунодефицитным состоянием, страдающих частыми острыми респираторными инфекциями | |
| Pesut et al. | Bilateral pulmonary shadows and incapsulated mediastinal effusion in a patient with respiratory blastoschizomycosis | |
| Palmer et al. | Can Multi-Drug Resistant Organisms (MDRO) Be Treated By Aerosolized Antibiotics? | |
| Corris et al. | A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |